Cleared Traditional

AccuCheck (K223834) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223834 · Manteia Technologies Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
210d
Days
Class 2
Risk

K223834 is an FDA 510(k) clearance for the AccuCheck. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Manteia Technologies Co., Ltd. (Xiamen, CN). The FDA issued a Cleared decision on July 20, 2023 after a review of 210 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Manteia Technologies Co., Ltd. devices

Submission Details

510(k) Number K223834 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2022
Decision Date July 20, 2023
Days to Decision 210 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 107d · This submission: 210d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 216
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K223834.
Halcyon, Ethos Radiotherapy System
K232113 · Varian Medical Systems, Inc. · Nov 2023
TrueBeam, TrueBeam STx, Edge, VitalBeam
K231317 · Varian Medical Systems, Inc. · Sep 2023
IDENTIFY
K230576 · Varian Medical Systems, Inc. · Jul 2023
Radixact Treatment Delivery System
K223159 · Accuray Incorporated · Jun 2023
MapRT
K231185 · Vision Rt, Ltd. · Jun 2023
SIDDHARTH-II
K222762 · Panacea Medical Technologies Pvt. , Ltd. · Jun 2023